Rune Labs and Medtronic Partner to Evaluate Use of Medtronic BrainSense™ Data in Rune’s Software for Precision Neurology

SAN FRANCISCO: SAN FRANCISCO, Nov. 2, 2021 /PRNewswire/ -- Rune Labs, a company using aggregated brain data to empower the development and delivery of precision medicines for neurological and psychiatric diseases, and Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced a new project designed to better understand...

Click to view original post